• Publications
  • Influence
Social phobia.
  • M. Liebowitz
  • Medicine
  • Modern problems of pharmacopsychiatry
  • 1987
The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats
Results of this study suggest that the self-report version of the LSAS compares well to the clinician-administered version and may be validly employed in the assessment of social anxiety disorder. Expand
Social phobia. Comorbidity and morbidity in an epidemiologic sample.
Social phobia was associated with distress and impairment, yet was rarely treated by mental health professionals, and an increase in suicide attempts was found among subjects with social phobia overall, but this increase was mainly attributable to comorbid cases. Expand
Psychometric properties of the Liebowitz Social Anxiety Scale.
The LSAS appears to be a reliable, valid and treatment sensitive measure of social phobia, and the pattern of correlations of LSAS subscales with one another and with the other measures suggest that the fear subscales and the avoidance subscales may not be sufficiently distinct in clinical samples. Expand
Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale
Social phobia has become a focus of increased research since its inclusion in DSM-III. However, assessment of social phobia has remained an underdeveloped area, especially self-report assessment.Expand
Empirical validation and psychometric evaluation of the Brief Fear of Negative Evaluation Scale in patients with social anxiety disorder.
Standard scoring of the BFNE may not be optimal for patients with social anxiety disorder, and confirmatory factor analysis indicated a 2-factor solution to be more appropriate. Expand
Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.
Results of the acute treatment phase of a 2-site study comparing cognitive behavioral group therapy (CBGT) and treatment with the monoamine oxidase inhibitor phenelzine sulfate for social phobia suggest that these treatments can be efficacious at facilities with differing theoretical allegiances. Expand
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Intensive exposure and ritual prevention may be superior to clomipramine and, by implication, to monotherapy with the other SRIs and their combination are all efficacious treatments for OCD. Expand
Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder
Objective:The purpose of the study was to test the relative and combined efficacy of clomipramine and exposure and ritual prevention in the treatment of obsessive-compulsive disorder (OCD) in adults.Expand
Functional impairment in social phobia.
Social phobia is associated with impairment in most areas of functioning, and the new scales appear useful in assessing functional impairment related to social phobia. Expand